与衰老相关的神经退行性疾病中的神经调节细胞死亡:关键途径和治疗潜力
Run Song1,2, Shiyi Yin1,2, Jiannan Wu2
1Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan Province, China.
Neural regeneration research
|August 6, 2024
概括
调节的细胞死亡途径,包括铁和,在神经元衰老中至关重要. 了解它们的交音可能会揭示治疗与年龄相关的神经退行性疾病的生物标志物.
科学领域:
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 调节细胞死亡 (RCD) 途径在神经元衰老和死亡中至关重要.
- 失调的RCD有助于与衰老相关的疾病.
- 七种RCD形式,包括新型铁亡和亡,都与神经退行有关.
研究的目的:
- 审查了解与年龄相关疾病中的七种RCD形式的最新进展.
- 探索RCD形式之间的信号通路和交叉声,专注于铁,和二硫.
- 突出与年龄相关的神经退行性疾病的潜在治疗点.
主要方法:
- 关于RCD机制及其在衰老中的作用的文献综述.
- 分析信号通路,分子效应器和RCD形式之间的交叉通话.
- 专注于铁,杯和脱硫的机制和相互联系.
主要成果:
- 铁和杯与认知障碍和神经退行性疾病有关.
- 这些RCD形式促进炎症,氧化应激和蛋白质聚合.
- FDX1诱导铜;铜增强铁;抑制Xc-可以导致二硫化.
结论:
- 新的RCD形式,如铁和,为神经退行提供了新的见解.
- 了解RCD路径之间的交叉通话是区分它们的关键.
- 确定RCD目标可能会导致用于逆转衰老和治疗神经退行性疾病的生物标志物.
相关概念视频
Aging
40
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
40
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171


